2018 annual financial data
Seres Therapeutics 2018 Net margin
Direct answer
Net margin was -350.03%.
Operating income was -100,284,000 USD and net income was -98,942,000 USD.
Operating cash flow was -62,854,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,267,000 USD
- Operating income
- -100,284,000 USD
- Net income
- -98,942,000 USD
- Operating cash flow
- -62,854,000 USD